In a latest press launch,
The Curaleaf Millcreek location will be discovered at 4934 West Ridge Road, Erie, PA 16506. With the brand new facility, it presents shoppers an “improved in-store layout, streamlined ordering process, and enhanced customer flow,” (1).
“Adding a second dispensary in Erie marks an important step in how we continue to evolve our retail footprint in Pennsylvania,” stated Boris Jordan, Chairman and CEO of Curaleaf (1). “This new location allows us to deliver a more convenient, welcoming, and elevated experience for patients, while expanding access to our trusted brands and award-winning product innovation. We look forward to serving the Erie community and welcoming both new and returning customers to Curaleaf Millcreek.”
A grand opening for the brand new location shall be held on Saturday, December 27, 2025. Those in attendance will be capable of obtain particular promotions, presents with their purchases, and participate in giveaways.
Curaleaf International and Jupiter Research LLC Announce EU Medical Device Certification
In a May 2025 press launch,
The gadget shall be labeled as a certifiedClass IIa medical gadget and meets the regulatory requirements in Europe (2). The press launch (2) talked about that “A comprehensive technical file and full EU Declaration of Conformity were assessed and approved by a recognized EU Notified Body, validating the device’s quality, safety, and clinical robustness.” It additionally detailed that the gadget comprises a magnetic snap-in cartridge, in addition to an influence provide that’s rechargeable.
With the certification from the EU, healthcare professionals will be capable of advocate the gadget in European nations, Canada, areas all through Australasia, and the UK (2). Additionally, the gadget will be capable of be provided in numerous international markets as soon as it has been commercialized.
Boris Jordan, Chairman and CEO of Curaleaf, stated (2), “Achieving EU medical certification is more than a regulatory milestone—it’s a signal that medical cannabis innovation is moving into the mainstream of global healthcare. We’re proud to offer a device that meets the highest standards of safety and quality, and we look forward to supporting patients and healthcare providers across Europe and beyond with a new, accurate and discrete option for treatment.”
TILT’s Chief Executive Officer Tim Conder, commented (2), “Partnering with Curaleaf International on this project has been a natural extension of our long-standing partnership in the US. By delivering industry-leading, user-friendly solutions, our collaboration exemplifies how technology can revolutionise healthcare. Achieving EU medical certification on IP developed by our subsidiary Jupiter Research, validates the robustness of our engineering and R&D functions and sets a new benchmark for the industry.”
References
- Curaleaf opens second Erie Dispensary in Millcreek, Pennsylvania
https://www.prnewswire.com/news-releases/curaleaf-opens-second-erie-dispensary-in-millcreek-pennsylvania-302649562.html (accessed Jan 2, 2026). - Colli, M. Curaleaf International and Jupiter Research Partnership receive EU Medical Device Certification for first liquid inhalation gadget
https://www.cannabissciencetech.com/view/curaleaf-international-and-jupiter-research-partnership-obtain-eu-medical-device-certification-for-first-liquid-inhalation-device (accessed Jan 2, 2026).